CIK 0001641631 · Non-accelerated filer<br>Smaller reporting company
Beyond Air, Inc.
Sign in to watch- Ticker
- XAIR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473812456
- Phone
- 516-665-8200
- Business address
- 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530
- Former names
- AIT Therapeutics, Inc., KokiCare, Inc.
- Open-market buys, last 90 days
- $62,352
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,352. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-22 | Carey Robert Director | Returned to the company · Stock Options (Right to buy) | −1,000 | 0 | ||
| 2024-11-22 | Carey Robert Director | Grant or award · Stock Options (Right to buy) | +1,000 | 1,000 | ||
| 2024-11-22 | Carey Robert Director | Returned to the company · Stock Options (Right to buy) | −25,000 | 0 | ||
| 2024-11-22 | Carey Robert Director | Grant or award · Stock Options (Right to buy) | +25,000 | 25,000 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Returned to the company · Stock Options (Right to buy) | −950,000 | 0 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Stock Options (Right to buy) | +950,000 | 950,000 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Returned to the company · Stock Options (Right to buy) | −800,000 | 0 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Stock Options (Right to buy) | +800,000 | 800,000 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Returned to the company · Stock Options (Right to buy) | −280,000 | 0 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Stock Options (Right to buy) | +280,000 | 280,000 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Returned to the company · Stock Options (Right to buy) | −200,000 | 0 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Stock Options (Right to buy) | +200,000 | 200,000 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Returned to the company · Stock Options (Right to buy) | −70,000 | 0 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Stock Options (Right to buy) | +70,000 | 70,000 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Returned to the company · Stock Options (Right to buy) | −250,000 | 0 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Stock Options (Right to buy) | +250,000 | 250,000 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Returned to the company · Stock Options (Right to buy) | −400,000 | 0 | ||
| 2024-11-22 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Stock Options (Right to buy) | +400,000 | 400,000 | ||
| 2024-09-27 | Carey Robert Director | Other acquisition · Warrants to purchase Common Stock | +9,886,633 | 9,886,633 | ||
| 2024-09-27 | Lisi Steven A. CEO and Chairman of the Board | Other acquisition · Warrants to purchase Common Stock | +3,295,544 | 3,295,544 |
Page 12 of 17 · 328 trades